On the other hand, TMZ, as a single agent, was not as effective as pG8-FasL/FADD in enhancing the survival of tumor bearing mice, albeit the difference between the median survival time for both treatment regimens was not statistically significant. This evidence concerns the gene FASLG and neoplasm.